SNT 2.94% 3.3¢ syntara limited

News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis, page-8

  1. 1,829 Posts.
    lightbulb Created with Sketch. 76
    I'm not sure why you would expect the SP to go up today?  After all, the BI Phase iia trial is "old" news.   (unless I have missed something new in today's announcement).   This has been available on the clinical trials website for quite some time: https://clinicaltrials.gov/ct2/show/NCT03166735

    What is more interesting/relevant is that the end date of the trial is 9 months away, even for a 12 week trial.  These things take time............
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
-0.001(2.94%)
Mkt cap ! $42.58M
Open High Low Value Volume
3.3¢ 3.3¢ 3.3¢ $6.417K 194.4K

Buyers (Bids)

No. Vol. Price($)
3 106747 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 228097 1
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.